| Name | Title | Contact Details |
|---|
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of end stage kidney disease (ESKD). Pathalys` initial asset is upacicalcet, a novel calcimimetic with the potential to improve the treatment of SHPT in hemodialysis patients. Beyond upacicalcet, Pathalys continues to identify other high priority needs and potential solutions for patients with ESKD. Pathalys is headquartered in Research Triangle Park, North Carolina.
More than an OEM company, IntriCon is invested in creating a hearing healthcare system to offer individuals hearing help at a cost they can afford.
UNO HEALTHCARE was established in 1996 and we provide specialty support for patients to acquire pharmaceuticals not available in their countries.
Piramal Critical Care is a Boise, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SK Biopharmaceuticals is a Fairfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.